50 results on '"Payancé, Audrey"'
Search Results
2. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
3. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors
4. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
5. Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation
6. Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort
7. Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study
8. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation
9. Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis
10. Management of splanchnic vein thrombosis
11. WED-071 The association of hepatocyte large extracellular vesicles with plasma biomarkers levels improve prediction of mortality in patients with cirrhosis
12. WED-177 Determination of liver biopsy quality criteria for the diagnosis of porto-sinusoidal vascular disorder (PSVD)
13. WED-135-YI Impact of metabolic alterations on liver phenotype of patients with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ)
14. OS-080 Performance of spleen stiffness measurement by vibration-controlled transient elastography to rule out high-risk varices in patients with chronic extrahepatic portal vein obstruction without cirrhosis
15. TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ genotype) provides evidence for clinical patient management
16. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases
17. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease
18. Anticoagulation for Budd–Chiari Syndrome
19. Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
20. Predictive Role of Hepatic Venous Pressure Gradient in Bleeding Events Among Cirrhotic Patients Undergoing Orthotopic Liver Transplantation
21. Budd-Chiari Syndrome: The Western Perspective
22. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome
23. Pregnancy in idiopathic non-cirrhotic portal hypertension: A multicentric study on maternal and fetal management and outcome
24. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
25. Performance of spleen stiffness measurement by vibration-controlled transient elastography to rule out high-risk varices in patients with porto-sinusoidal vascular disorder
26. Anticoagulation for Budd–Chiari Syndrome
27. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma
28. Rivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis
29. Hepatic venous pressure gradient in sinusoidal obstruction syndrome: Diagnostic value and link with histological lesions
30. Liver Stiffness by Transient Elastography to Detect Porto‐Sinusoidal Vascular Liver Disease With Portal Hypertension
31. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease
32. OS-121-YI - Performance of spleen stiffness measurement by vibration-controlled transient elastography to rule out high-risk varices in patients with porto-sinusoidal vascular disorder
33. Angioplasty with stenting for Budd-Chiari syndrome
34. Pregnancy and vascular liver diseases
35. Recent (non-cirrhotic) extrahepatic portal vein obstruction
36. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma
37. Cirrhosis regression: extrahepatic angiogenesis and liver hyperarterialization persist
38. Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis
39. A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis
40. Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study.
41. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
42. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine
43. Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab
44. Maladies vasculaires du foie.
45. Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?
46. Les microvésicules: sur la route menant du laboratoire de recherche au laboratoire d’analyses médicales.
47. Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long AreWe Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?
48. Longitudinal evaluation of individuals with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype).
49. Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder.
50. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.